Optimizing Chitosan-based Posaconazole Dry Powder Formulation Using Box-Behnken Design: The Role of Leucine in Enhancing Performance.

Singh SK, Pancholi SS

Open source

DOI
10.2174/0118715265376840250717072610
Published
2026
Container
Infectious disorders drug targets
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2174/0118715265376840250717072610,
  title = {Optimizing Chitosan-based Posaconazole Dry Powder Formulation Using Box-Behnken Design: The Role of Leucine in Enhancing Performance.},
  author = {Singh SK and Pancholi SS},
  year = {2026},
  journal = {Infectious disorders drug targets},
  doi = {10.2174/0118715265376840250717072610},
  url = {https://doi.org/10.2174/0118715265376840250717072610}
}

RIS

TY  - JOUR
TI  - Optimizing Chitosan-based Posaconazole Dry Powder Formulation Using Box-Behnken Design: The Role of Leucine in Enhancing Performance.
AU  - Singh SK
AU  - Pancholi SS
PY  - 2026
JO  - Infectious disorders drug targets
DO  - 10.2174/0118715265376840250717072610
UR  - https://doi.org/10.2174/0118715265376840250717072610
ER  - 

APA

SK, S., & SS, P. (2026). Optimizing Chitosan-based Posaconazole Dry Powder Formulation Using Box-Behnken Design: The Role of Leucine in Enhancing Performance.. Infectious disorders drug targets. https://doi.org/10.2174/0118715265376840250717072610

Source records